Literature DB >> 3979072

Unprecedented sedative requirements during delirium tremens.

K B Nolop, A Natow.   

Abstract

A 34-yr-old male in delirium tremens required a total of 2640 mg iv diazepam for adequate sedation. Doses of benzodiazepines clearly must be individualized, and doses higher than those currently recommended may be required.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3979072     DOI： 10.1097/00003246-198504000-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


  6 in total

1.  A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens.

Authors:  Jeffrey A Gold; Binaya Rimal; Anna Nolan; Lewis S Nelson
Journal:  Crit Care Med       Date:  2007-03       Impact factor: 7.598

Review 2.  Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment.

Authors:  R C Turner; P R Lichstein; J G Peden; J T Busher; L E Waivers
Journal:  J Gen Intern Med       Date:  1989 Sep-Oct       Impact factor: 5.128

3.  Use of propofol as adjuvant therapy in refractory delirium tremens.

Authors:  Rajiv Mahajan; Rakendra Singh; Pir Dutta Bansal; Ranju Bala
Journal:  Ind Psychiatry J       Date:  2010-01

4.  Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal.

Authors:  Riley J Lizotte; John A Kappes; Billie J Bartel; Katie M Hayes; Veronica L Lesselyoung
Journal:  Clin Pharmacol       Date:  2014-10-31

5.  Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation.

Authors:  Poorvi Shah; Marc McDowell; Reika Ebisu; Tabassum Hanif; Theodore Toerne
Journal:  J Med Toxicol       Date:  2018-05-10

6.  Twenty-Eight-Day-Long Delirium Tremens.

Authors:  Paritosh Kafle; Amrendra Kumar Mandal; Binav Shrestha; Bikash Bhattrai; Manjul Bhandari; Shambhu Bhagat; Bijoy Shankar Kar; Dikshya Sharma; Vijay Gayam
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.